Extracellular Matrix Associated Protein CYR61 is Linked to Prostate Cancer Development

Journal of Urology

Volumn 183, Issue 4, 2010, Pages 1604-1610

  D'Antonio, Katherine B ^a   Toubaji, Antoun ^c   Albadine, Roula ^c   Mondul, Alison M ^d   Platz, Elizabeth A ^a,b,d   Netto, George J ^c   Getzenberg, Robert H ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

biological markers; cysteine rich protein 61; microarray analysis; prostate; prostatic neoplasms

Indexed keywords

CYSTEINE RICH PROTEIN 61;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; CYSTEINE-RICH PROTEIN 61; HUMANS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 77949307078     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.12.006     Document Type: Article

References (30)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71
2. Parekh D.J., Ankerst D.P., Troyer D., et al. Biomarkers for prostate cancer detection. J Urol 178 (2007) 2252
3. Browne T.J., Hirsch M.S., Brodsky G., et al. Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens. Hum Pathol 35 (2004) 1462
4. Chen C.C., Chen N., and Lau L.F. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J Biol Chem 276 (2001) 10443
5. Chen C.C., Mo F.E., and Lau L.F. The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts. J Biol Chem 276 (2001) 47329
6. Grzeszkiewicz T.M., Kirschling D.J., Chen N., et al. CYR61 stimulates human skin fibroblast migration through Integrin alpha vbeta 5 and enhances mitogenesis through integrin alpha vbeta 3, independent of its carboxyl-terminal domain. J Biol Chem 276 (2001) 21943
7. Grzeszkiewicz T.M., Lindner V., Chen N., et al. The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans. Endocrinology 143 (2002) 1441
8. Kubota S., and Takigawa M. CCN family proteins and angiogenesis: from embryo to adulthood. Angiogenesis 10 (2007) 1
9. Lin M.T., Chang C.C., Chen S.T., et al. Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation. J Biol Chem 279 (2004) 24015
10. Liu H., Yang R., Tinner B., et al. Cysteine-rich protein 61 and connective tissue growth factor induce deadhesion and anoikis of retinal pericytes. Endocrinology 149 (2008) 1666
11. Chen C.C., Young J.L., Monzon R.I., et al. Cytotoxicity of TNFalpha is regulated by integrin-mediated matrix signaling. Embo J 26 (2007) 1257
12. Chen N., Leu S.J., Todorovic V., et al. Identification of a novel integrin alphavbeta3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells. J Biol Chem 279 (2004) 44166
13. Menendez J.A., Vellon L., Mehmi I., et al. A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway. Oncogene 24 (2005) 761
14. Lin M.T., Chang C.C., Lin B.R., et al. Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin alpha2beta1. J Biol Chem 282 (2007) 34594
15. Bleau A.M., Planque N., and Perbal B. CCN proteins and cancer: two to tango. Front Biosci 10 (2005) 998
16. Chen P.P., Li W.J., Wang Y., et al. Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer. PLoS ONE 2 (2007) e534
17. Feng P., Wang B., and Ren E.C. Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response. Int J Biochem Cell Biol 40 (2008) 98
18. Holloway S.E., Beck A.W., Girard L., et al. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer. J Am Coll Surg 200 (2005) 371
19. Pilarsky C.P., Schmidt U., Eissrich C., et al. Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancer. Prostate 36 (1998) 85
20. Prakash K., Pirozzi G., Elashoff M., et al. Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays. Proc Natl Acad Sci U S A 99 (2002) 7598
21. Sakamoto S., Yokoyama M., Aoki M., et al. Induction and function of CYR61 (CCN1) in prostatic stromal and epithelial cells: CYR61 is required for prostatic cell proliferation. Prostate 61 (2004) 305
22. Sun Z.J., Wang Y., Cai Z., et al. Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells. Br J Cancer 99 (2008) 1656
23. Goodwin A.C., Jadallah S., Toubaji A., et al. Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues. Prostate 68 (2008) 766
24. Gurel B., Iwata T., Koh C.K., et al. Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. Mod Pathol 21 (2008) 1156
25. Rhodes D.R., Yu J., Shanker K., et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6 (2004) 1
26. Humphrey P.A. Diagnosis of adenocarcinoma in prostate needle biopsy tissue. J Clin Pathol 60 (2007) 35
27. Haas C.S., Creighton C.J., Pi X., et al. Identification of genes modulated in rheumatoid arthritis using complementary DNA microarray analysis of lymphoblastoid B cell lines from disease-discordant monozygotic twins. Arthritis Rheum 54 (2006) 2047
28. Hilfiker-Kleiner D., Kaminski K., Kaminska A., et al. Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation. Circulation 109 (2004) 2227
29. Sakamoto S., Yokoyama M., Prakash K., et al. Development of quantitative detection assays for CYR61 as a new marker for benign prostatic hyperplasia. J Biomol Screen 8 (2003) 701
30. Sakamoto S., Yokoyama M., Zhang X., et al. Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid. Endocrinology 145 (2004) 2929